Bain Capital Life Sciences Fund IV, 10% Owner of Kailera Therapeutics KLRA, has filed 2 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $25M. The latest trade was on 04/20.

BI

BI

Bain Capital Life Sciences Fund IV

10% Owner

Company

Kailera Therapeutics KLRA

First filing

25/01/13

Trades

8 trades

Buys / sales

2 / 0

12-month net buying

$25M

Last trade

04/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kailera TherapeuticsKLRA	Open-market buy	04/20	04/20	1,562,500 sh	$16.00	$25,000,000	+7.4%
Olema PharmaceuticalsOLMA	Open-market buy	25/01/08	25/01/13	300,000 sh	$5.76	$1,728,000	+4.0%